PremiumThe FlyTruqap approved for PTEN-deficient metastatic hormone-sensitive prostate cancer2d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s AZD1390 ADME Study Lays Groundwork for Future Oncology Upside2d agoAZN